4- (3-Tosyl-2- (tosylmethyl) propanoyl) benzoic acid-glu (PEG24-Me) -val-cit-NH-benzyloxyformic acid-MMAE
Selected Variant
HY-178219-01
Size: 5 mg
4- (3-Tosyl-2- (tosylmethyl) propanoyl) benzoic acid-glu (PEG24-Me) -val-cit-NH-benzyloxyformic acid-MMAE is a drug-linker conjugate for ADC. 4- (3-Tosyl-2- (tosylmethyl) propanoyl) benzoic acid-glu (PEG24-Me) -val-cit-NH-benzyloxyformic acid-MMAE contains a linker and bioactive small molecule toxins MMAE. 4- (3-Tosyl-2- (tosylmethyl) propanoyl) benzoic acid-glu (PEG24-Me) -val-cit-NH-benzyloxyformic acid-MMAE can conjugate with NN2101 (HY-P991293) (anti c-Kit) for synthesizing NN3201. NN3201 rapidly internalizes and inhibits SCF-driven signaling, thereby delivering its payload to induce cell cycle arrest and apoptosis. NN3201 exhibits significant c-Kit-dependent anti-tumor efficacies in various tumor models, such as small cell lung cancer (SCLC) and gastrointestinal stromal tumor (GIST).
Product Specifications
UNSPSC
12352005
Target
Apoptosis; Drug-Linker Conjugates for ADC; Microtubule/Tubulin
Related Pathways
Antibody-drug Conjugate/ADC Related; Apoptosis; Cell Cycle/DNA Damage; Cytoskeleton
Applications
Cancer-programmed cell death
Field of Research
Cancer
Purity
97.88
Smiles
Molecular Formula
C138H223N11O44S2
Molecular Weight
2804.42
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Price
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog